Trials / Completed
CompletedNCT01439295
Ascorbyl Peroxide Association With Bronchopulmonary Dysplasia
Urinary Ascorbyl Peroxide as an Early Biological Marker of Bronchopulmonary Dysplasia in Preterm Infants Less Than 33 Weeks of Gestation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 51 (actual)
- Sponsor
- St. Justine's Hospital · Academic / Other
- Sex
- All
- Age
- 23 Weeks – 32 Weeks
- Healthy volunteers
- Not accepted
Summary
Urinary ascorbyl peroxide level in the first week of life will be a good predictor of Bronchopulmonary dysplasia (BPD) in preterm infants less than 33 weeks of gestation.
Detailed description
This study uses ascorbyl peroxide as representative of oxidative stress in premature infants on parenteral nutrition and aims to test the correlation of this metabolite and the different major neonatal outcomes 'mainly bronchopulmonary dysplasia).
Conditions
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2011-09-23
- Last updated
- 2015-11-18
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01439295. Inclusion in this directory is not an endorsement.